FDA Approves Xospata
FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation
November 28, 2018 -- The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients w
FDA Approves Firdapse
FDA Approves Firdapse (amifampridine) for Lambert-Eaton Myasthenic Syndrome
November 28, 2018 -- The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic sy
FDA Updates on Angiotensin II Receptor Blocker (ARB) Recalls
Give Thanks for These Foods That Help Preserve Aging Memory
WEDNESDAY, Nov. 21, 2018 -- When your mom told you to eat your veggies and drink your orange juice, she was on to something: They may help preserve your brain health, new research suggests.
A
FDA Approves Daurismo
FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia
November 21, 2018 -- The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (L
FDA Approves Gamifant
FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis
1November 20, 2018 -- The U.S. Food and Drug Administration today approved Gamifant (emapalumab) for the treatment of pediatric (newborn and a